Genmab A/S 2014 SR
The report for 2014 highlights Genmab's commitment to improving patient lives through innovative antibody products, specifically focusing on cancer treatments. Key focus areas include employee well-being, ethics in clinical studies, environmental impact, and business transparency. In 2014, the company launched its 2025 vision externally and achieved a low employee turnover rate of 2%. Genmab also met its gender diversity goal, with women representing 54% of the total workforce and 44% at the director level and above. The company continues to prioritize ethical vendor selection and environmental initiatives like using wind-generated power at its Copenhagen site.
Company: Genmab A/S
Sector: Professional & technical services
Country: Denmark
Year: 2014
Type: SR
Pages: 9
Genmab A/S
The report for 2014 highlights Genmab's commitment to improving patient lives through innovative antibody products, specifically focusing on cancer treatments. Key focus areas include employee well-being, ethics in clinical studies, environmental impact, and business transparency. In 2014, the company launched its 2025 vision externally and achieved a low employee turnover rate of 2%. Genmab also met its gender diversity goal, with women representing 54% of the total workforce and 44% at the director level and above. The company continues to prioritize ethical vendor selection and environmental initiatives like using wind-generated power at its Copenhagen site.
Sign in for free to access detailed sustainability data, reporting standards, and ESG metrics.
Document Details
Report Year
2014
Reporting Period
Jan 1, 2014 - Dec 31, 2014
Fiscal Year
2014
Type
Sustainability Report
Language
English
Pages
File Size
Standards & Assurance
Materiality Assessment
Other Standards
ESG Data?Experimental: AI-extracted data, may contain inaccuracies
Women in Management
Employees